Morphine Sul 50mg/ml Inj , 20ml
Overview
What is this medicine?
How to Use This Medicine
To use this medication correctly, follow your doctor's instructions and read all the information provided. It's essential to follow the dosage instructions carefully. This medication is administered via injection into a muscle, vein, or the fatty tissue under the skin.
Storing and Disposing of Your Medication
If you need to store this medication at home, consult with your doctor, nurse, or pharmacist for guidance on proper storage.
Missing a Dose
If you miss a dose, contact your doctor to determine the best course of action.
Lifestyle & Tips
- Avoid alcohol and other sedating medications unless approved by your doctor, as this can increase the risk of serious side effects like extreme drowsiness or trouble breathing.
- Do not drive or operate heavy machinery until you know how this medication affects you, as it can cause dizziness and drowsiness.
- Report any signs of severe constipation to your healthcare provider, as this is a common side effect and may require treatment.
- If you are receiving this medication at home, ensure it is stored securely and out of reach of children and pets to prevent accidental ingestion.
Available Forms & Alternatives
Available Strengths:
- Morphine Sulf Rect 20mg Suppository
- Morphine Sul 10mg Rect Suppository
- Morphine Sulf Rect 30mg Suppository
- Morphine Sulf Rect 5mg Suppository
- Morphine Sul 15mg ER Tabs (12h)
- Morphine Sul 30mg ER Tabs (12h)
- Morphine Sul 60mg ER Tabs (12h)
- Morphine Sulf 100mg ER Tabs (12h)
- Morphine Sulf 200mg ER Tabs (12h)
- Morphine Sul 50mg/ml Inj , 20ml
- Morphine Sul 50mg/ml Inj, 50ml
- Morphine Sul 1mg/ml Inj 10ml
- Morphine Sul 30mg Imm Rel Tab
- Morphine Sul 15mg Imm Rel Tab
- Morphine Sul 10mg/5ml(2mg/ml) Sol
- Morphine Sul 20mg/5ml(4mg/ml) Sol
- Morphine Sulf 100mg/5ml(20mg/ml)sol
- Morphine Sul 10mg/ml Inj, 1ml
- Morphine Sul 10mg ER Caps (24h)
- Morphine Sul 30mg ER Caps (24h)
- Morphine Sul 60mg ER Caps (24h)
- Morphine Sul 45mg ER Caps (24h)
- Morphine Sul 75mg ER Caps (24h)
- Morphine Sul 90mg ER Caps (24h)
- Morphine Sulf 120mg ER Caps (24h)
- Morphine Sul 80mg ER Caps (24h)
- Morphine Sul 30mg ER Caps (24h)
- Morphine Sul 20mg ER Caps(24h)
- Morphine Sul 50mg ER Caps(24h)
- Morphine Sulf 100mg ER Caps (24h)
- Morphine Sul 4mg/ml Inj, 1ml
- Morphine Sulf 100mg/5ml(20mg/ml)sol
- Morphine Sulfate 2mg/ml Inj 1ml
- Morphine Sulf Inj 4mg/ml 1ml Syr
- Morphine Sul 2mg/ml Inj 1ml
- Morphine Sul 8mg/ml Inj, 1ml
- Morphine Sul 30mg ER Tabs
- Morphine Sulfate 4mg/ml Inj, 1ml
- Morphine Sulfate 10mg/ml Inj, 1ml
- Morphine Sul 0.5mg/ml Inj, 5ml
- Morphine Sul 8mg/ml Inj, 1ml Vial
Dosing & Administration
Adult Dosing
Condition-Specific Dosing:
Pediatric Dosing
Dose Adjustments
Renal Impairment:
Hepatic Impairment:
Pharmacology
Mechanism of Action
Pharmacokinetics
Absorption:
Distribution:
Elimination:
Pharmacodynamics
Safety & Warnings
BLACK BOX WARNING
Side Effects
Although rare, some people may experience severe and potentially life-threatening side effects while taking this medication. If you notice any of the following symptoms, contact your doctor immediately or seek emergency medical attention:
Signs of an allergic reaction, such as:
+ Rash or hives
+ Itching or red, swollen, blistered, or peeling skin (with or without fever)
+ Wheezing or tightness in the chest or throat
+ Difficulty breathing, swallowing, or talking
+ Unusual hoarseness or swelling of the mouth, face, lips, tongue, or throat
Signs of low blood sugar, including:
+ Dizziness or lightheadedness
+ Headache or feeling sleepy
+ Weakness, shaking, or a rapid heartbeat
+ Confusion, hunger, or sweating
Severe dizziness or fainting
Chest pain or pressure, or a rapid heartbeat
Confusion or disorientation
Breathing difficulties, including:
+ Slow or shallow breathing
+ Noisy breathing
+ Sleep apnea (breathing problems during sleep)
Seizures
Severe constipation or stomach pain, which may indicate a bowel problem
Depression or mood changes
Swelling in the arms or legs
Fever, chills, or sore throat
Painful urination
Abnormal sensations, such as burning, numbness, or tingling
Serotonin syndrome, a potentially life-threatening condition that may occur when taking this medication with certain other drugs. Symptoms include:
+ Agitation or changes in balance
+ Confusion or hallucinations
+ Fever or rapid heartbeat
+ Flushing or muscle twitching
+ Seizures or shivering
+ Excessive sweating, diarrhea, or vomiting
+ Severe headache
Adrenal gland problems, which may cause:
+ Extreme fatigue or weakness
+ Fainting or severe dizziness
+ Upset stomach, vomiting, or decreased appetite
Hormonal changes, including:
+ Decreased sex drive
+ Fertility problems
+ Irregular menstrual periods or ejaculation problems
Additional Side Effects (Injection into the Spine)
If you receive this medication via injection into the spine, you may experience:
Loss of movement or muscle spasms
Difficulty controlling body movements
Urination problems
Other Possible Side Effects
Most people taking this medication will not experience severe side effects. However, some may encounter mild or moderate side effects, including:
Dizziness, drowsiness, or fatigue
Dry mouth
Constipation, diarrhea, stomach pain, or decreased appetite
Headache or anxiety
Excessive sweating
If you experience any of these side effects or have concerns about your medication, contact your doctor for guidance. You can also report side effects to the FDA at 1-800-332-1088 or online at https://www.fda.gov/medwatch.
Seek Immediate Medical Attention If You Experience:
- Slow or shallow breathing (less than 10 breaths per minute for adults)
- Extreme drowsiness or difficulty waking up
- Bluish lips or fingernails
- Severe dizziness or lightheadedness when standing up
- Confusion or disorientation
- Severe constipation or abdominal pain
- Signs of an allergic reaction (rash, itching, swelling, severe dizziness, trouble breathing)
Before Using This Medicine
To ensure safe treatment, inform your doctor about the following:
Any allergies you have to this medication, its components, or other substances, including foods and drugs. Describe the allergic reaction you experienced, such as symptoms and signs.
Existing health conditions, including:
+ Respiratory issues like asthma, breathing difficulties, or sleep apnea
+ Elevated carbon dioxide levels in the blood
+ Stomach or bowel obstruction or narrowing
Recent use (within the last 14 days) of certain medications for depression or Parkinson's disease, such as isocarboxazid, phenelzine, tranylcypromine, selegiline, or rasagiline, as this may lead to severely high blood pressure
Current use of the following medications: buprenorphine, butorphanol, linezolid, methylene blue, nalbuphine, or pentazocine
Additional Considerations for Spinal Injection:
Presence of an infection at the injection site
Bleeding disorders
* Use of blood thinners
This list is not exhaustive, and it is crucial to inform your doctor and pharmacist about all your medications (prescription, over-the-counter, natural products, and vitamins) and health issues. Verify that it is safe to take this medication with your existing treatments and health conditions. Never start, stop, or adjust the dosage of any medication without consulting your doctor.
Precautions & Cautions
To minimize the risk of dizziness or fainting, get up slowly from a sitting or lying position. Be cautious when climbing stairs.
Do not combine this medication with other potent pain relievers or use a pain patch without first consulting your doctor. If your pain worsens, you experience increased sensitivity to pain, or you develop new pain after taking this medication, contact your doctor immediately. Adhere to the prescribed dosage and avoid taking more than ordered.
Long-term or high-dose use of this medication can lead to tolerance, where the drug becomes less effective, and you may require higher doses to achieve the same effect. If you find that this medication is no longer working as well as it should, consult your doctor. Do not exceed the prescribed dosage.
Prolonged or regular use of opioid medications like this one can result in dependence. Suddenly reducing the dose or stopping the medication altogether may increase the risk of withdrawal or other severe complications. Before decreasing the dose or discontinuing this medication, consult your doctor and follow their instructions. Report any increased pain, mood changes, suicidal thoughts, or other adverse effects to your doctor.
If you have a sulfite allergy, discuss this with your doctor, as some products contain sulfites. Avoid consuming alcohol or using products that contain alcohol, as this can lead to unsafe and potentially fatal consequences.
This medication may increase the risk of seizures in certain individuals, including those with a history of seizures. Consult your doctor to determine if you are at a higher risk of seizures while taking this medication.
If you are 65 or older, use this medication with caution, as you may be more susceptible to side effects. Inform your doctor if you are breastfeeding, as this medication can pass into breast milk and potentially harm your baby. Seek immediate medical attention if your baby appears excessively sleepy, limp, or has breathing difficulties.
Overdose Information
Overdose Symptoms:
- Pinpoint pupils
- Extreme drowsiness or unresponsiveness
- Slow, shallow, or stopped breathing
- Bluish skin, especially around the lips and fingertips
- Limp muscles
- Cold, clammy skin
- Loss of consciousness
What to Do:
Seek immediate emergency medical attention. Call 911 or your local emergency number. Administer naloxone if available and trained to do so. Provide rescue breathing if necessary. Call 1-800-222-1222 (Poison Control Center).
Drug Interactions
Contraindicated Interactions
- Monoamine Oxidase Inhibitors (MAOIs): Concomitant use or within 14 days of MAOI discontinuation due to risk of severe, unpredictable reactions including serotonin syndrome or respiratory depression.
Major Interactions
- Benzodiazepines and other CNS depressants (e.g., other opioids, alcohol, sedatives, hypnotics, general anesthetics, phenothiazines, tranquilizers, skeletal muscle relaxants, gabapentinoids): Increased risk of profound sedation, respiratory depression, coma, and death.
- Mixed agonist/antagonist opioids (e.g., butorphanol, nalbuphine, pentazocine): May precipitate opioid withdrawal symptoms or reduce analgesic effect.
- Serotonergic drugs (e.g., SSRIs, SNRIs, TCAs, triptans, mirtazapine, tramadol): Risk of serotonin syndrome.
- Anticholinergic drugs (e.g., atropine, scopolamine, tricyclic antidepressants): Increased risk of urinary retention and severe constipation, paralytic ileus.
Moderate Interactions
Minor Interactions
- Not available
Monitoring
Baseline Monitoring
Rationale: To establish baseline pain level and guide initial dosing.
Timing: Prior to first dose
Rationale: To assess baseline respiratory function and risk of respiratory depression.
Timing: Prior to first dose
Rationale: To assess baseline mental status and risk of excessive sedation.
Timing: Prior to first dose
Rationale: To assess baseline cardiovascular status and risk of hypotension/bradycardia.
Timing: Prior to first dose
Rationale: To identify potential impairment that may require dose adjustment.
Timing: Prior to initiation, especially in patients with known or suspected impairment
Routine Monitoring
Frequency: Every 1-2 hours initially after IV/IM/SC dose, then as clinically indicated (e.g., every 3-4 hours or before each dose)
Target: Patient-specific pain goal (e.g., 0-3 on 0-10 scale)
Action Threshold: Pain score above goal, requiring additional dose or intervention
Frequency: Every 15-30 minutes for 1-2 hours after IV dose, then every 1-4 hours or as clinically indicated
Target: Adults: >10-12 breaths/min, regular rhythm; Pediatrics: Age-appropriate normal range
Action Threshold: Respiratory rate <10 breaths/min (adults), shallow breathing, or signs of hypoventilation
Frequency: Every 15-30 minutes for 1-2 hours after IV dose, then every 1-4 hours or as clinically indicated
Target: Alert or mildly drowsy, easily aroused
Action Threshold: Difficult to arouse, somnolent, or unarousable
Frequency: Every 1-4 hours or as clinically indicated
Target: Within patient's normal range
Action Threshold: Significant hypotension or bradycardia
Frequency: Daily
Target: Regular bowel movements
Action Threshold: Constipation, abdominal distension, or absence of bowel sounds
Symptom Monitoring
- Respiratory depression (slow, shallow breathing)
- Excessive sedation/somnolence
- Nausea and vomiting
- Constipation
- Pruritus (itching)
- Urinary retention
- Dizziness/lightheadedness
- Hypotension
- Pupil constriction (miosis)
Special Patient Groups
Pregnancy
Use during pregnancy is generally not recommended unless the potential benefit justifies the potential risk to the fetus. Prolonged use during pregnancy can lead to neonatal opioid withdrawal syndrome (NOWS).
Trimester-Specific Risks:
Lactation
Morphine is excreted into breast milk. While generally considered compatible with breastfeeding for short-term, single-dose use, chronic use or high doses are not recommended due to risk of infant sedation, respiratory depression, and withdrawal.
Pediatric Use
Use with extreme caution, especially in neonates and infants, due to increased sensitivity to respiratory depression and variable metabolism. Dosing must be weight-based and carefully titrated. Close monitoring for respiratory depression and sedation is crucial.
Geriatric Use
Start with lower doses and titrate slowly due to increased sensitivity to opioid effects (e.g., respiratory depression, sedation, constipation) and potential for decreased renal and hepatic function. Monitor closely for adverse effects.
Clinical Information
Clinical Pearls
- Always have naloxone readily available when administering morphine, especially in opioid-naΓ―ve patients or when titrating doses.
- Rapid IV administration can lead to histamine release, causing flushing, itching, and hypotension. Administer IV doses slowly (over 4-5 minutes).
- Morphine-6-glucuronide (M6G), an active metabolite, accumulates in renal impairment, leading to prolonged and enhanced opioid effects. Dose reduction is crucial in kidney disease.
- Tolerance and physical dependence can develop with prolonged use. Do not abruptly discontinue after chronic use to avoid withdrawal symptoms.
- Assess patient's pain, sedation level, and respiratory status frequently, especially during the first few hours after initiation or dose escalation.
- Prophylactic laxatives (stimulant and stool softener) should be initiated with chronic opioid therapy to prevent opioid-induced constipation.
Alternative Therapies
- Other strong opioid analgesics (e.g., hydromorphone, fentanyl, oxycodone)
- Moderate opioid analgesics (e.g., codeine, tramadol)
- Non-opioid analgesics (e.g., NSAIDs, acetaminophen)
- Adjuvant analgesics (e.g., gabapentin, pregabalin, tricyclic antidepressants for neuropathic pain)
- Regional anesthesia/nerve blocks
- Non-pharmacological pain management (e.g., physical therapy, acupuncture, cognitive behavioral therapy)
Cost & Coverage
General Drug Facts
This medication is accompanied by a Medication Guide, which provides crucial information for safe use. Read this guide carefully and review it again whenever your prescription is refilled. If you have any questions or concerns about this medication, discuss them with your doctor, pharmacist, or other healthcare provider.
In the event of an overdose, a medication called naloxone can be administered to help treat the condition. Consult your doctor or pharmacist about obtaining and using naloxone. If you suspect an overdose has occurred, seek immediate medical attention, even if naloxone has been administered. Be prepared to provide detailed information about the overdose, including the substance taken, the amount, and the time it occurred, to facilitate prompt and effective treatment.